| Financial Year |
March 31 2023 |
| Monetary Funds |
5,246,138,118.67 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,508,420.00 |
| Accounts Receivable |
677,305,935.06 |
| Advances to Suppliers |
50,895,355.65 |
| Other Receivables |
8,156,675.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
17,606,635.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,036,934,976.00 |
| Total Current Assets |
8,041,546,116.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
516,508,123.63 |
| Investment Properties |
320,175,853.43 |
| Fixed Assetes |
7,851,560,396.38 |
| Under-construction Projects |
2,684,837,998.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,520,951,965.94 |
| R&D expenses |
26,302,473.73 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,656,562.59 |
| Deferred Income Tax Assets |
547,789,719.86 |
| Other Non-Current Assets |
99,671,412.46 |
| Sub-Total of Non-Current Assets |
14,215,182,316.03 |
| Total Assets |
22,256,728,432.76 |
| Short-Term Loans |
20,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
417,041,738.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
86,725,003.94 |
| Taxes Payable |
28,447,883.76 |
| Interest Payable |
-- |
| Dividend Payable |
8,080,089.40 |
| Other payables |
108,952,097.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
24,502,861.33 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,647,005,732.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
873,370,864.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,338,532,527.89 |
| Total Liabilities |
2,985,538,259.90 |
| Paid-In Capital(Or Share Stock) |
4,224,385,412.00 |
| Capital Surplus |
7,790,195,091.58 |
| Surplus Reserve |
270,315,501.08 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,802,914,494.34 |
| Minority Stockholder's Interest |
4,056,121,593.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,215,068,579.61 |
| Owner's Equity（Stockholder's Equity） |
19,271,190,172.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,256,728,432.76 |
